#Marburg in Tanzania (outbreaks 2023 & 2025): genome sequencing shows the strains were near-identical (>99.71% identity). Likely local spillover + limited human-to-human spread → need stronger eco/behavioral studies + surveillance in the Great Lakes zone. https://cdc.pulse.ly/otayrzokqs

Rwanda’s #Marburg response cut fatality rates to ~23% through rapid surveillance, genomics & coordinated action. A clear case for sustained investment in preparedness and research infrastructures. Nature Medicine: https://www.nature.com/articles/s41591-025-04163-y

#Nipah virus remains a high-risk pandemic threat with up to 70% fatality and no licensed vaccine. A new Nature Health Comment highlights urgent needs for better diagnostics, standardized assays, and vaccine-ready models to strengthen global outbreak preparedness. https://nature.pulse.ly/7dktxy8mw4

The EU has allocated €1.2 million in emergency aid to support the response to the Marburg outbreak in southern Ethiopia, strengthening surveillance, patient care, contact tracing and community engagement through WHO, International Medical Corps and the Red Cross. https://europa.pulse.ly/n3mybebsgd

🧪 As a partner in #ISIDORe, #ERINHA contributes its expertise on high-risk pathogens and preparedness, supporting Europe’s capacity to respond to emerging infectious diseases. 👉 Read on CORDIS: https://shorturl.at/k1SyC #ResearchInfrastructures #InfectiousDiseases #EUProjects

Emerging infectious diseases New in Nature: the oral antiviral 4′-fluorouridine protected non-human primates from lethal Lassa fever when administered at an advanced stage of infection. Read more: https://www.nature.com/articles/s41586-025-09906-y #HighConsequencePathogens #AntiviralResearch

🦇 Hendra virus detected in a bat in Australia’s Northern Territory (first confirmed NT detection; test 11 Dec 2025). Authorities say risk remains unchanged, but surveillance & biosecurity matter to reduce spillover risk. https://daf.nt.gov.au/news/2025/first-nt-detection-of-hendra-virus-in-a-bat

🔬 In Bangladesh, 5 severe “Nipah-like” cases linked to raw date palm sap tested NiV-negative. Sequencing identified Pteropine orthoreovirus (PRV), highlighting the need for broad surveillance & differential diagnosis in spillover settings. https://wwwnc.cdc.gov/eid/article/31/12/25-0797_article#;

One Health Trial Design could speed up #Lassa vaccine trials by combining ecological surveillance + viral genomics + socio-behavioral monitoring → smarter site selection + better case accrual + stronger real-world effectiveness estimates. https://www.nature.com/articles/s41591-025-04018-6

🧬 Lessons from the 2016 Ebola outbreak helped accelerate the first Lassa fever vaccine, now in Phase 1 human trials (Oxford + CEPI). The ChAdOx1 platform (used for COVID-19) will next be tested in Ghana, with plans for later trials in Nigeria. Read more: https://shorturl.at/b4M7w

🔬 New study in npj Viruses identifies cross-neutralizing antibodies that protect against both Marburg and Ravn viruses, two deadly filoviruses with no approved treatments. Lead candidates showed 100% protection in animal models. 👉 https://www.nature.com/articles/s44298-025-00168-z

⚠️ Nigeria: Lassa fever CFR reaches 18.2% (Week 50, 2025): 1,097 confirmed cases, 201 deaths across 21 states. No approved Lassa fever vaccine yet—highlighting the need for stronger preparedness and research. https://shorturl.at/yOR5d

🧬 Preparedness for high-risk pathogens: mRNA vaccines advance against Nipah virus.mRNA-LNP candidates targeting NiV F and G proteins provide robust immunity and full protection in hamsters — underlining the value of high-containment research. https://www.nature.com/articles/s41541-025-01336-1

🦠🌍 Zoonotic spillovers are rising. Deforestation, urbanization, intensive farming & climate change increase human–wildlife contact and outbreak risk. #OneHealth Read more: https://shorturl.at/mBNFV!/

🦠 H5N1: a warning worth taking seriously Finland became the first country to vaccinate high-risk groups against #H5N1 after a major outbreak in fur farms. Human cases are still rare, but the virus is spreading widely in animals and could mutate https://www.nature.com/articles/d41586-025-03612-5

🔬 New work in PLOS Pathogens shows how human gut #organoids can advance research on #Ebola and #Marburg virus infections in human-relevant systems: https://shorturl.at/V2GcS 🧩 How advanced in vitro models and high-containment infrastructures support preparedness in infectious disease research.

🚨 Big step for epidemic preparedness: Oxford just vaccinated the first volunteer in a first-in-human trial of the ChAdOx1 #Lassa fever vaccine. No licensed vaccine exists yet, ViTaL01 will assess safety + immune response. Read more: https://openaccessgovernment.pulse.ly/hxnmbzomou

UKHSA has found a new recombinant #mpox variant in England, mixing clade Ib + clade IIb — proof mpox is still evolving. Vaccination remains key for eligible risk groups. https://www.theguardian.com/world/2025/dec/08/england-health-officials-identify-newly-evolved-strain-of-mpox

France has confirmed 2 imported #MERS-CoV cases in travellers returning from a shared trip to the Arabian Peninsula. Patients are stable, hospitalized as a precaution. No secondary transmission detected so far. Contact tracing, testing & isolation measures are in place. https://urlr.me/YvhwdH

#Marburg update – Ethiopia (Dec 7, 2025) Cumulative total: 13 confirmed / 8 deaths (62% CFR) / 4 recovered / 1 active case, from 1,428 tests Response boosted with donated monoclonal antibody + intensive contact tracing. https://outbreaknewstoday.substack.com/p/marburg-monoclonal-antibody-donated

Ethiopia reports 3 deaths from #Marburg virus in its first confirmed outbreak. Marburg spreads through direct contact with bodily fluids and has a high fatality rate. Read more: https://www.aljazeera.com/news/2025/11/17/ethiopia-confirms-three-marburg-deaths-as-outbreak-sparks-regional-alarm

Great news from the #CCHFVACIM project! Colleagues just published a new rapid pseudotyped neutralisation assay for high-risk bunyaviruses, including CCHFV. Fast, adaptable, safe — and a major boost for vaccine development & Disease X preparedness. https://www.nature.com/articles/s41541-025-01278-8

New standard for BSL-4 research: MIHCLE Transparency, accountability & safety in high-containment science. #MIHCLE #ERINHA 👉 Read the Nature Comment : www.nature.com/articles/s41... #biosafety #biosecurity #MIHCLE #researchstandards #ERINHA #BSL4

A new milestone for outbreak readiness: 100,000 investigational #Nipah vaccine doses to be produced by CEPI, Oxford & Serum Institute. Built on the ChAdOx platform that helped fight COVID19. #GlobalHealth #Vaccines Read more: https://cepi.net/establishing-worlds-largest-nipah-virus-vaccine-reserve

🧬 A breakthrough for safer virus research By delivering purified nucleocapsids directly into cells—bypassing receptor-mediated infection—they open the door to non-infectious, biosafe approaches for studying and handling dangerous viruses. More: https://www.nature.com/articles/s41598-025-22282-x

EMA workshop: Non-clinical data for regulatory decision-making on the efficacy of medical countermeasures | European Medicines Agency (EMA) https://www.ema.europa.eu/en/events/ema-workshop-non-clinical-data-regulatory-decision-making-efficacy-medical-countermeasures

Read our correspondence in #Nature: Give the public a say in virology safeguards: https://rdcu.be/eOcx4

A wave of ancient plagues 5000 years ago changed everything — our DNA, immunity & societies. Read the beautifully illustrated story in New Scientist:https://www.newscientist.com/article/2500060-how-a-surge-in-ancient-plagues-5000-years-ago-shaped-humanity/ #AncientDNA #HumanEvolution #OneHealth

As Europe warms, #Hyalomma ticks carrying #CCHFV expand northward. https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-025-07104-3 The #CCHFVACIM project unites partners across Europe to boost vaccine development & preparedness. #OneHealth #ERINHA

Nigeria faces another #Lassa fever surge — 18.6% fatality rate. Preparedness, not panic, must define the response. Read more: https://www.nationalaccordnewspaper.com/how-prepared-is-nigeria-for-another-lassa-fever-season/

🧪 Scientific Watch Rapid detection of high-consequence #infections in febrile travellers. ➡️ Results in under 1 hour, 85.7% sensitivity, 96% specificity. Fast diagnostics = faster decisions, less unnecessary isolation. 📌 Ref: https://sciencedirect.pulse.ly/qp3z7oa1ik

🧬 New Lancet Infectious Diseases study: children face >2x higher risk of Long COVID after reinfection. Even mild reinfections matter — prevention & monitoring remain key. At ERINHA, we support research that strengthens global preparedness. 🌍 https://thelancet.pulse.ly/ys4eabkfp0

🦠 The Republic of Congo is reinforcing Ebola preparedness with @WHO support — training staff, updating plans & strengthening surveillance. At #ERINHA, we share this commitment to global health security through biosafety research & collaboration. Preparedness must be global. 🌍 #Ebola #OneHealth

🇪🇺 Great to see our Director General Jonathan Ewbank representing #ERINHA at the Science|Business event in Brussels — discussing how to strengthen Europe’s life sciences innovation ecosystem. Research infrastructures like ERINHA are key to boosting competitiveness and pandemic preparedness!

🧬 New study: combining ecology, evolution & AI could help predict which viruses may jump species next. A step toward forecasting outbreaks, not just reacting. #ViralEmergence #OneHealth #PandemicPreparedness #AI #ERINHA Read more: https://www.nature.com/articles/s41598-025-01176-y

🌍 #Africa faces multiple outbreaks: 🦠 #Mpox surges in Kenya, Zambia & Senegal 💧 #Cholera cases near 300k 🧬 #Ebola in DRC shows decline after 9,000 vaccinations Need for stronger #OneHealth surveillance & research capacity is clear. Read more: https://umn.pulse.ly/nna2xf3uve

Stay informed with our Scientific Watch series on the #NAVIPP website:: https://navipp.pulse.ly/6iyth3mbgt This series explores the latest scientific insights — and reveals how they connect to NAVIPP’s mission. Each story reminds us: preparedness today builds resilience for tomorrow.

🦠 New #Ebola outbreak declared in Kasai (DRC): 35 cases, 16 deaths so far. Rapid response by @WHO, @UNICEF & partners underway. A stark reminder of the need for strong #biosafety, #research infrastructures & preparedness. #GlobalHealth #ERINHA Read more: https://thelancet.pulse.ly/gnmixfglz9

🔬 Recent review by Sikkema and Koopmans: pandemic preparedness requires more than speed — it needs sustained research, coordination & high-containment capacity. #OneHealth #Biosafety #ERINHA Read the whole piece in Nature Reviews Microbiology:https://nature.pulse.ly/ngwftypggs

🦠 #EU mobilises emergency support to #DRC as Ebola outbreak hits Kasai (64 cases, 42 deaths). 🚁 Air ops, €1.8M aid, & EU experts deployed via @eu_echo & @WHO. HERA funds new vaccines & diagnostics for filoviruses. #Ebola #GlobalHealth #HERA #ERINHA Read more: https://europa.pulse.ly/dmoqz1fwy2

🚨 On 4 Sept 2025, DRC declared an Ebola outbreak in Kasai. WHO & partners launched a strategic plan to: - Contain the outbreak - Protect communities - Strengthen long-term resilience Collaboration & preparedness remain key to safeguarding health. Read more: www.afro.who.int/publications...

A recent debate highlighted the need for international, harmonized standards to ensure that critical work on dangerous pathogens is conducted safely and transparently. https://nature.pulse.ly/qox5kjtp1o We are committed to foster global collaboration & contribute to a safer research environment.

🌍 ERINHA will be at #BIOSPAIN2025! On Oct 8 (12:15, Barcelona), Jonathan Ewbank will join the roundtable “Europe at the Helm: Rethinking Strategic Autonomy in an Uncertain World”. Proud to contribute to shaping Europe’s biotech future. 👉 Learn more about BIOSPAIN 2025: https://www.biospain.com

🚨 Ebola outbreak in DRC: 48 cases, 31 deaths, including 4 health workers. Deaths surged +63% in one week. WHO warns urgent action is needed to contain the spread. Risk to the US remains low, but global preparedness is key. #INTERCEPTOR Read more: https://unilad.pulse.ly/tnm6zkmtsf

🌐 New on the CCHFVACIM website! CCHFVACIM brings together 15 international partners to accelerate vaccines and immunotherapies against Crimean-Congo haemorrhagic fever virus (CCHFV), a WHO priority pathogen with epidemic and pandemic potential. 👉 Explore all updates here: www.cchfvacim.eu

🚨 Following the #Ebola outbreak in the #DRC, WHO is launching a US$ 21 million appeal to help the country: - Scale up operations - Interrupt transmission chains - Prevent further spread - Mitigate the impact on human health Full donor support is critical to halt the outbreak 👉 bit.ly/3KtjsVG

🔬 Upcoming EBSA Online Course ISO/TS5441:2024 Competence Requirements for Biorisk Management Advisors 📅 September 24th, 2025 🕙 10:00 – 12:00 CET 👩‍🏫 Instructor: Ursula Jenal 👉 Register: https://ebsaweb.pulse.ly/wp70a5cqpe

We are launching #NAVIPP Scientific Watch Series: Join us on this journey The articles you’ll find in this series explore recent discoveries, and show how they connect to NAVIPP’s mission. Each story is a reminder: preparedness today means resilience tomorrow. https://www.navipp.eu/news/

🦇 Scientists in Australia discovered Salt Gully virus, a new henipavirus found in flying foxes. No current risk, but a key reminder: wildlife surveillance = pandemic preparedness. 🌍 Read the full article: https://cdc.pulse.ly/ebjpqeyzll

🚨 Ebola vaccination starts in Bulape, DRC. 400 Ervebo doses deployed, 45,000 more approved. WHO: high risk nationally, low globally. #Ebola #DRC #GlobalHealth Read more: https://who.pulse.ly/e5kovcynnz